How Dr. Dennis Gross Skincare Leads Dermatology-Driven Beauty

5 Min Read
Disclosure: This website may contain affiliate links, which means we may earn a commission if you click on the link and make a purchase. We only recommend products or services that we've personally vetted and that provide added value to our readers.

Designed for at-home use and professional results, the brand is globally recognized for its innovative technologies like the Alpha Beta Daily Peel, LED devices, and advanced anti-aging skincare. In October 2025, global beauty conglomerate Shiseido announced it would acquire Dr. Dennis Gross Skincare, marking a new era of expansion and R&D for the brand.

Dr. Dennis Gross Skincare has revolutionized the industry by bringing high-level, dermatologist-formulated care to consumers everywhere.

How Does It Work?

Driven by science and clinical data, Dr. Dennis Gross Skincare products bridge the gap between in-office results and daily routines:

  • Peels and Serums: The iconic Alpha Beta Daily Peel uses a unique two-step formula of AHAs and BHAs to safely deliver radiance, reduce fine lines, and improve tone. Over two decades, the peel has expanded for multiple skin types—Extra Strength, Ultra Gentle, and the original. As Dr. Gross describes: “I have been a strong advocate for 2-step peel exfoliation because it is the safest and most gentle way to exfoliate”.
  • Device Innovation: Products like the SpectraLite EyeCare Pro—an FDA-cleared professional LED light therapy device—bring in-office treatments home for anti-aging and firmness, with dry skincare as the next frontier.
  • Barrier Repair and Support: Scientifically proven actives upregulate moisture barrier proteins, supporting overall health and resilience of the skin.
  • Inclusive Results: All formulas are tested and optimized for a range of skin tones and types, maximizing accessibility and efficacy.

Origin Story & Founders

Founded in 2000 by Dr. Dennis Gross—former skin cancer researcher and leading NYC dermatologist—and his wife Carrie Gross (CEO), the brand began with a mission to create professional-quality skincare for all. It started from Dennis’s Manhattan office, where patients asked for at-home solutions as effective as his signature peels. With Carrie’s creative and wellness background, they built a trusted namesake line that brought clinical results and deep expertise to mass beauty retail. 

Ownership & Major Milestones

  • 2000: Brand founded by Dr. Dennis Gross and Carrie Gross in New York City.
  • Grows from professional offices to prestige retail, expanding into serums, LED tools, and spa distribution.
  • Clinical trials show patented peels boost collagen, protect barrier function, and serve diverse skin types. The brand receives private equity backing from Main Post Partners.
  • October 2025: Announced acquisition by Shiseido Americas Corporation (a subsidiary of Tokyo-based Shiseido) to join a portfolio with Clé de Peau Beauté and SHISEIDO.

Benefits for Consumers

  • Professional Results at Home: Safe, effective alternatives to office procedures.
  • Real Clinical Data: All claims are backed by peer-reviewed studies and user trials.
  • Sustainable Choices: Recyclable packaging, cruelty-free policies, and efforts to minimize product waste.
  • Education First: Free access to masterclasses and resources empowers everyone to understand their skin and ingredients.

The Alpha Beta Daily Peel supports overall skin health by improving collagen, density, and the moisture barrier—gently and for all skin.

Applications for Sellers

  • Clinically tested, best-selling, and celebrity-endorsed, Dr. Dennis Gross Skincare is carried by Sephora, Nordstrom, Space NK, Selfridges, and on Amazon.
  • Key partnerships with spas, luxury wellness destinations, and professional channels expand brand presence.
  • New tech, such as boosters for HydraFacial and professional LEDs, drives treatment menu innovation for spas and cosmetic offices worldwide.

Future Outlook

Now backed by Shiseido’s global R&D and commercial reach, Dr. Dennis Gross Skincare will accelerate innovation in dermatology-powered beauty. International expansion, new spa and clinical partnerships, and the launch of novel devices and dry skincare products are top priorities. 

As Shiseido CEO Masahiko Uotani says, “This transaction is well-aligned with Shiseido’s 2030 goal of becoming a personal beauty wellness company that supports people in realizing unique beauty and wellness throughout their lives. Dr. Dennis Gross Skincare is the perfect complement to our global portfolio of prestige brands as their core values are aligned with ours in terms of their scientific and innovative approach to beauty and our people-first culture”.

Share This Article